CorMedix Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
8.4 -2.67
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
8.4
Max
8.79
Pajamos | 25M 39M |
|---|---|
Pardavimai | -1.2M 127M |
P/E Sektoriaus vid. | 4.065 50.958 |
Pelnas, tenkantis vienai akcijai | 0.35 |
Pelno marža | 30.293 |
Darbuotojai | 191 |
EBITDA | -289K 66M |
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +69.85% upside |
Kitas uždarbis | 2026-08-06 |
|---|
Rinkos kapitalizacija | 91M 692M |
|---|---|
Ankstesnė atidarymo kaina | 11.07 |
Ankstesnė uždarymo kaina | 8.4 |
Naujienos nuotaikos
By Acuity
50%
50%
146 / 342 reitingas Healthcare
CorMedix Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
